Decreased dependence of myelin basic protein-reactive T cells on CD28- mediated costimulation in multiple sclerosis patients: A marker of activated/memory T cells

Journal of Clinical Investigation

Volumn 101, Issue 4, 1998, Pages 725-730

  Lovett Racke, Amy E ^a   Trotter, John L ^a   Lauber, Joanne ^a   Perrin, Peter J ^b   June, Carl H ^c   Racke, Michael K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Costimulation; Immunological memory; Multiple sclerosis; Myelin basic protein; T cells

Indexed keywords

ANTIBODY; CD28 ANTIGEN; HLA ANTIGEN; MYELIN BASIC PROTEIN; TETANUS TOXOID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; STROKE; T LYMPHOCYTE;

EID: 0032519421     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1528     Document Type: Article

References (32)

1. Ota, K., M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler. 1990. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
2. Martin, R., D. Jaraquemada, M. Flerlage, J. Richert, J. Whitaker. E.O. Long, D.E. McFarlin, and H.F. McFarland. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540-548.
3. Zhang, J.W., R. Medaer, Y. Chin, E. van den Berg-Loonen, and J.C.M. Raus, 1992. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 32:330-339.
4. Joshi, N., K. Usuku, and S.L. Hauser, 1993. The T cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements, and T cell receptor usage. Ann. Neurol. 34:385-393.
5. Allegretta, M., J.A. Nicklas, S. Sriram, and R.J. Albertini. 1990. T cells responsiveness to myelin basic protein in patients with multiple sclerosis. Science.247:718-721.
6. Trotter, J.L., C.A. Damico, A.H. Cross, C.M. Pelfrey, R.W. Karr, X.-T. Fu, and H.F. McFarland. 1997. HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides. J. Neuroimmunol. 75:95-103.
7. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H.L. Weiner, and D.A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973-984.
8. Sagerstrom, C.G., E.M. Keir, J.P. Allison, and M.M. Davis. 1993. Activation and differentiation requirements of primary T cells in vitro. Proc. Natl. Acad. Sci. USA. 90:8987-8991.
9. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science. 248:1349-1356.
10. Gimmi, C.D., G.J. Freeman, J.G. Gribben, G. Gray, and L.M. Nadler. 1993. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA. 90:6586-6590.
11. Liu, Y., and CA. Janeway. 1992. Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc. Natl. Acad. Sci. USA. 89:3845-3849.
12. Walunas, T.L., D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Freeman, J.M. Green, C.B. Thompson, and J.A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:405-413.
13. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe, 1995. Loss of CTLA-4 leads to massive lymphoproliferative and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
14. Perrin, P.J., J.H. Maldonado, T.A. Davis, C.H. June, and M.K. Racke. 1996. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol. 157:1333-1336.
15. Ferez, V.L., L.V. Parijs, A. Biuckians, X.X. Zheng, T.B. Strom, and A.K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6:411-117.
16. Karandikar, N.J., C.L. Vanderlugt, T.L. Walunas, S.D. Miller, and J.A. Bluestone. 1996. CTLA-4: A negative regulator of autoimmune disease. J. Exp. Med. 184:783-788.
17. M. Croft, L.M. Bradley, and S.L. Swain. 1994. Naive versus memory CD4 T cell response to antigen: Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152:2675-2685.
18. Weiss, A., B. Manger, and J. Imboden. 1986. Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells. J. Immunol. 137:819-825.
19. Taswell, C. 1984. Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single Poisson model. J. Immunol. Methods. 72:29-10.
20. Damle, N.K., J.A. Hansen, R.A. Good, and S. Gupta. 1981. Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc. Natl. Acad. Sci. USA. 78:5096-5098.
21. Racke, M.K., D.E. Scott, L. Quigley, G.S. Gray, R. Abe, CH. June, and P.J. Perrin. 1995. Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:2195-2203.
22. Wucherpfennig, K. W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
23. Hemmer, B., B.T. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K.H. Wiesmuller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185:1651-1659.
24. Harris, J.O., J.A. Frank, N. Patronas, D.E. McFarlin, and H.F. McFarland. 1991. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implication for clinical trials and natural history. Ann. Neurol. 29:548-555.
25. Stone, L.A., P.S. Albert, M.E. Smith, C. DeCarli, M.R. Armstrong, D.E. McFarlin, J.A. Frank, and H.F. McFarland. 1995. Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology. 45:1808-1814.
26. Kawaguchi, M., and D.D. Eckels. 1995. Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells. Hum. Immunol. 43:136-148.
27. Lovett-Racke, A.E., R. Martin, H.F. McFarland, M.K. Racke, and U. Utz. 1997. Longitudinal study of myelin basic protein-specific T cell receptors during the course of multiple sclerosis. J. Neuroimmunol. 78:162-171.
28. Windhagen, A., J. Newcombe, F. Dangond, C. Strand, M.N. Woodroofe, M.L. Cuzner, and D.A. Hafler. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985-1996.
29. Currier, R.D., E.A. Martin, and P.C. Woosley. 1974. Prior events in multiple sclerosis. Neurology. 24:748-754.
30. Yi-qun, Z., R.J.J. van Neerven, A. Kasran, M. de Boer, and J.L. Ceuppens. 1996. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int. Immunol. 8:37-44.
31. Perrin, P.J., D. Scott, L. Quigley, P.S. Albert, O. Feder, G.S. Gray, R. Abe, C.H. June, and M.K. Racke. 1995. The role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunnol. 154:1481-1490.
32. Miller, S.D., C.L. Vanderlugt, D.J. Lenschow, J.G. Pope, N.J. Karandikar, M.C. Dal Canto, and J.A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:739-745.